EU case definitions

Case definitions for each infectious disease covered by EU surveillance, as published in the Official Journal of the European Union (Commission Implementing Decision (EU) 2018/945).

Diseases

Anthrax

Avian influenza in humans

Botulism

Brucellosis

Campylobacteriosis

Chikungunya virus disease

Chlamydia infections

Cholera

(COVID-19)

Creutzfeldt-Jakob disease, variant (vCJD)

Cryptosporidiosis

Dengue

Diphtheria

Echinococcosis

Giardiasis

Gonorrhoea

Hepatitis A

Hepatitis B

Hepatitis C

HIV infection and AIDS

Infections with haemophilus influenza group B

Influenza including Influenza A(H1N1)

Invasive meningococcal disease

Invasive pneumococcal disease

Legionnaires’ disease

Leptospirosis

Listeriosis

Lyme neuroborreliosis

Malaria

Measles

Meningococcal disease, invasive

Mumps

Pertussis

Plague

Pneumoccocal invasive diseases

Poliomyelitis

Q fever

Rabies

Rubella

Rubella, congenital

Salmonellosis

Severe Acute Respiratory Syndrome (SARS)

Shiga toxin /verocytotoxin -producing Escherichia coli (STEC/VTEC)

Shigellosis

Smallpox

Syphilis

Syphilis, congenital

Tetanus

Tick-borne encephalitis

Toxoplasmosis, congenital

Trichinellosis

Tuberculosis 

Tularaemia

Typhoid and paratyphoid fevers

Viral haemorrhagic fevers 

West Nile virus infection

Yellow fever

Yersinosis

Zika virus disease

Zika virus disease, congenital

Special health issues 

• Nosocomial infections
• Antimicrobial resistance

 
Disclaimer: The terminology used in the list above is based on the terminology used in the case definitions. Hence, the terminology may differ from the one in the Commission Implementing Decision on the communicable diseases and related special health issues to be covered by epidemiological surveillance – Annex 1 (replacing Commission Decision No 2000/96/EC).